Cite
HARVARD Citation
O'Reilly, M. et al. (n.d.). A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy. Leukemia & lymphoma. 55 (12), pp. 2950-2951. [Online].